Age-Related Macular Degeneration Forecasts Report 2016-2026 with Focus on 7 Major Markets

Dublin, April 13, 2016 -- Research and Markets has announced the addition of the "Age-Related Macular Degeneration Forecast in 7 Major Markets 2016-2026" report to their offering.

Age-related macular degeneration (AMD or ARMD) or Age-related Maculopathy (ARM) is a condition that involves the degeneration and damage to the central area of the retina - the macula. It is currently a common cause of visual impairment in Western Europe. AMD is typically painless, and the loss of central vision usually occurs in both eyes but may progress at different speeds.

This report provides the current prevalent population for AMD across 7 Major Markets (USA, France, Germany, Italy, Spain, UK and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of AMD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AMD include:

- Serous retinal detachment
- Haemorrhage
- Charles Bonnet Syndrome
- Depression
- Reduced quality of life
- Hypertension
- Hypercholesterolaemia (abdominal obesity is a specific risk factor for males)

Reasons to Buy:

- Able to quantify patient populations in global AMD's market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of AMD and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on AMD's prevalent population.
- Identify sub-populations within AMD which require treatment.
- Gain an understanding of the specific markets that have the largest number of AMD patients.

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers
- Additional data available on request

9. Top-Line Prevalence for Age-Related Macular Degeneration

10. Features of AMD Patients
- Severity and Type of AMD
- Early Type AMD
- Late Type AMD
- AMD Associated Conditions
- Exudative AMD Associated Conditions

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information visit http://www.researchandmarkets.com/research/4shx39/agerelated

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Pharmaceuticals